Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 23,550 KRW
Change Today +850.00 / 3.74%
Volume 207.8K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:28 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

Year over year, Daewon Pharmaceutical Co. Ltd. has been able to grow revenues from $143.5M USD to $164.3M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 47.27% to 45.64%. This was a driver that led to a bottom line growth from $11.1M USD to $14.2M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
KRW
Dec 31
2012
Restated
KRW
Dec 31
2013
Restated
KRW
Dec 31
2014
KRW
4 Year
Trend
Revenues125.4124.8143.5164.3
Other Revenues0.0------
TOTAL REVENUES125.4124.8143.5164.3
Cost of Goods Sold56.760.367.875.0
GROSS PROFIT68.764.475.689.3
Selling General & Admin Expenses, Total47.646.254.662.3
R&D Expenses5.14.35.29.1
Depreciation & Amortization, Total0.70.80.90.9
Other Operating Expenses3.21.00.91.0
OTHER OPERATING EXPENSES, TOTAL56.652.361.673.3
OPERATING INCOME12.112.214.016.1
Interest Expense-0.3-0.2-0.1-0.1
Interest and Investment Income0.30.60.70.7
NET INTEREST EXPENSE0.10.40.60.6
Currency Exchange Gains (Loss)0.1-0.10.10.1
Other Non-Operating Income (Expenses)-0.20.20.32.4
EBT, EXCLUDING UNUSUAL ITEMS12.012.715.019.2
Gain (Loss) on Sale of Investments-0.1-0.7-0.10.2
Gain (Loss) on Sale of Assets-0.10.0-0.20.0
Other Unusual Items, Total-0.5-0.7-0.7-0.4
EBT, INCLUDING UNUSUAL ITEMS11.311.314.119.1
Income Tax Expense3.02.53.05.0
Minority Interest in Earnings0.2-0.10.10.1
Earnings from Continuing Operations8.48.811.014.1
NET INCOME8.58.711.114.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS8.58.711.114.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS8.58.711.114.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 23,550.00 KRW +850.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 21.2x
Price/Sales 2.0x
Price/Book 2.9x
Price/Cash Flow 21.3x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.